In Vivo Regulation of p38 MAPK Activation in Human Endometrium and Endometriosis
article
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
This study investigated the in vivo regulation of p38 MAPK activation in human endometrium and endometriosis, identifying key pathways involved in these processes.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (4)
- Lipoxin A4 regulates expression of the estrogen receptor and inhibits 17β-estradiol induced p38 mitogen-activated protein kinase phosphorylation in human endometriotic stromal cells 2014
- SB203580, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis by down-regulating proinflammatory cytokines and proteolytic factors in a mouse model 2010
- [The action of p38 MAP kinase and its inhibitors on endometriosis]. 2010
- Non‐hormonal targets underlying endometriosis: A focus on molecular mechanisms 2015
Cited by (4)
- Non‐hormonal targets underlying endometriosis: A focus on molecular mechanisms 2015
- Lipoxin A4 regulates expression of the estrogen receptor and inhibits 17β-estradiol induced p38 mitogen-activated protein kinase phosphorylation in human endometriotic stromal cells 2014
- [The action of p38 MAP kinase and its inhibitors on endometriosis]. 2010
- SB203580, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis by down-regulating proinflammatory cytokines and proteolytic factors in a mouse model 2010
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0
· commercial use OK